AORT — ARTIVION, INC.

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 784199 ·
Last close
$18.27
Market Cap
$891.39M
52W High
$48.25
52W Low
$18.12
ADV30
704,675
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 123,790,000 75,977,000 2,947,000 -7,926,000 1,042,088,000 48,399,000 595,688,000
Jun 2026 125,757,000 80,517,000 -8,364,000 -13,510,000 1,071,934,000 77,316,000 626,349,000
Mar 2026 116,337,000 75,448,000 5,787,000 1,417,000 883,157,000 55,764,000 432,690,000
Dec 2025 115,992,000 73,143,000 7,180,000 2,426,000 884,796,000 64,908,000 436,564,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$41,710,000
Investing CF
$-175,028,000
Financing CF
$157,598,000
CapEx
$-50,867,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.07
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-63,591,000
Inventory
$103,364,000
Receivables
$110,763,000
ST Investments
—
EBIT TTM
$26,502,000
Pretax Income TTM
$2,233,000
Interest Exp TTM
$24,269,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$481,876,000
EBITDA
$55,557,000
Free Cash Flow
$-48,241,248
Enterprise Value
$1,344,673,920
Total Cash
$48,399,000
Total Debt
$407,027,008
Shares Out
48,790,000
Trailing EPS
$-0.36
Book Value
$9.15
ROE
-4.0%
ROA
1.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 441,330,000 26,745,000 9,768,000 884,796,000 436,564,000 448,232,000 39,880,000
Dec 2024 388,537,000 38,874,000 -13,359,000 789,101,000 512,901,000 276,200,000 22,236,000
Dec 2023 354,004,000 -8,508,000 -30,690,000 792,397,000 510,617,000 281,780,000 18,825,000
Dec 2022 313,789,000 6,201,000 -19,192,000 762,798,000 478,469,000 284,329,000 -5,153,000

TTM Snapshot

Revenues TTM
$471,474,000
NetIncome TTM
$-3,165,000
OpCashFlow TTM
—
Assets (Latest)
$1,071,934,000
Forward EPS
$0.63

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $15.00 · spot: $18.54 · call volume: 114 · put volume: 6
Expected Move to 2027-04-16: ±$4.15 (22.38%) — implied range $14.39 – $22.69 · ATM straddle on $17.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
KIDS ORTHOPEDIATRICS CORP $820.13M $31.41 —
BBNX Beta Bionics, Inc. $800.28M $14.72 —
CBLL Ceribell, Inc. $1.01B $25.97 —
SIBN SI-BONE, Inc. $1.04B $23.16 —
STVN Stevanato Group S.p.A. $759.94M $15.25 —

News headlines (Yahoo Finance, 1h cache)

AORT Q3 2026 deep dive: stent graft growth and NEXUS launch preparations shape outlook
2026-11-10 13:17 · Yahoo
Artivion (AORT) Stock Looks About Right Following Nexus Launch Preparations
2026-11-10 06:11 · Yahoo
Artivion Q3 Earnings Call Highlights
2026-11-07 00:14 · Yahoo
Artivion, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Artivion Inc (AORT) (Q3 2026) Earnings Call Highlights: Stent Graft Momentum and Nexus Launch ...
2026-11-06 09:20 · Yahoo
What Artivion (AORT)'s Revenue Growth And Loss Mean For Shareholders
2026-11-06 08:12 · Yahoo
Artivion (AORT) Q3 2026 Earnings Call Transcript
2026-11-06 06:46 · Yahoo
Artivion (AORT) Lags Q3 Earnings Estimates
2026-11-05 21:45 · Yahoo
Artivion’s (NYSE:AORT) Q3 2026 sales beat estimates
2026-11-05 21:36 · Yahoo
Artivion: Q3 Earnings Snapshot
2026-11-05 21:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.